• Do hypoglycemic agents reduce mortality in patients with type 2 diabetes? 

    Coney, L. S.; Narciso, Philipp (Family Physicians Inquiries Network, 2013-07)
    Metformin, sulfonylureas, and insulin, used with a target glycated hemoglobin (HbA1c) of 7% to 7.9%, reduce the overall mortality in patients with type 2 diabetes compared with diet therapy alone (SOR: B, RCTs). Although ...